Energy metabolism and rheumatic diseases: from cell to organism

In rheumatic and other chronic inflammatory diseases, high amounts of energy for the activated immune system have to be provided and allocated by energy metabolism. In recent time many new insights have been gained into the control of the immune response through metabolic signals. Activation of immune cells as well as reduced nutrient supply and hypoxia in inflamed tissues cause stimulation of glycolysis and other cellular metabolic pathways. However, persistent cellular metabolic signals can promote ongoing chronic inflammation and loss of immune tolerance. On the organism level, the neuroendocrine immune response of the hypothalamic-pituitary adrenal axis and sympathetic nervous system, which is meant to overcome a transient inflammatory episode, can lead to metabolic disease sequelae if chronically activated. We conclude that, on cellular and organism levels, a prolonged energy appeal reaction is an important factor of chronic inflammatory disease etiology.

[1]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.

[2]  K Lund-Olesen,et al.  Oxygen tension in synovial fluids. , 1970, Arthritis and rheumatism.

[3]  E. Goetzl,et al.  Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. , 1970, The American journal of medicine.

[4]  B. Henderson,et al.  Glycolytic activity in human synovial lining cells in rheumatoid arthritis. , 1979, Annals of the rheumatic diseases.

[5]  F. Buttgereit,et al.  ConA induced changes in energy metabolism of rat thymocytes , 1992, Bioscience Reports.

[6]  G. Semenza,et al.  Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. , 1993, The Journal of biological chemistry.

[7]  L. Adams,et al.  Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[8]  I. Rahman,et al.  Hypoxia prolongs neutrophil survival in vitro , 1995, FEBS letters.

[9]  B. Posner,et al.  Endosomal proteolysis of internalized proteins , 1996, FEBS letters.

[10]  T. Kataoka,et al.  Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity. , 1997, Immunology letters.

[11]  M. Birnbaum,et al.  Signaling Pathways Mediating Insulin‐Stimulated Glucose Transport , 1999, Annals of the New York Academy of Sciences.

[12]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[13]  G. Burmester,et al.  Bioenergetics of immune functions: fundamental and therapeutic aspects. , 2000, Immunology today.

[14]  A. Hollander,et al.  Expression of Hypoxia-Inducible Factor 1 a by Macrophages in the Rheumatoid Synovium Implications for Targeting of Therapeutic Genes to the Inflamed Joint , 2001 .

[15]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[16]  A. Perl,et al.  Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[17]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[18]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[19]  R. Straub,et al.  Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[21]  R. Jaenisch,et al.  HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.

[22]  P. Schur,et al.  Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. , 2003, Arthritis and rheumatism.

[23]  N. Tritos.  Corticosteroid insufficiency in acutely ill patients. , 2003, The New England journal of medicine.

[24]  Till Acker,et al.  Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis , 2004, Circulation research.

[25]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[26]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[27]  C. Print,et al.  Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.

[28]  Hiroshi Nakamura,et al.  TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells1 , 2005, The Journal of Immunology.

[29]  T. Gaber,et al.  Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! , 2005, Annals of the rheumatic diseases.

[30]  A. Perl,et al.  Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[31]  Russell G. Jones,et al.  Revving the engine: signal transduction fuels T cell activation. , 2007, Immunity.

[32]  J. Pedersen-Lane,et al.  Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients , 2007, Journal of leukocyte biology.

[33]  Yong Zhao,et al.  The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. , 2007, Transplant immunology.

[34]  C. P. Winlove,et al.  Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. , 2008, The Journal of hand surgery.

[35]  S. Moncada,et al.  Mitochondrial dysfunction and HIF1α stabilization in inflammation , 2008, Journal of Cell Science.

[36]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[37]  A. Ohta,et al.  Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia , 2008, Clinical Cancer Research.

[38]  J. Rathmell,et al.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. , 2008, Blood.

[39]  A. Scheffold,et al.  Human CD4+ T cells maintain specific functions even under conditions of extremely restricted ATP production , 2008, European journal of immunology.

[40]  D. Furst,et al.  Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. , 2009, Arthritis and rheumatism.

[41]  J. Hamilton,et al.  Hypoxia Prolongs Monocyte/Macrophage Survival and Enhanced Glycolysis Is Associated with Their Maturation under Aerobic Conditions1 , 2009, The Journal of Immunology.

[42]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[43]  S. Panda,et al.  AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation , 2009, Science.

[44]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[45]  G. Schett,et al.  Hypoxia in the pathogenesis of systemic sclerosis , 2009 .

[46]  E. Procko,et al.  Antigen processing and presentation: TAPping into ABC transporters. , 2009, Current opinion in immunology.

[47]  S. Gay,et al.  Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis , 2009, Arthritis research & therapy.

[48]  K. Fritsche,et al.  A Role for the ATP7A Copper-transporting ATPase in Macrophage Bactericidal Activity* , 2009, The Journal of Biological Chemistry.

[49]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[50]  Qicheng Ma,et al.  Activation of a metabolic gene regulatory network downstream of mTOR complex 1. , 2010, Molecular cell.

[51]  T. Holowka,et al.  Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. , 2010, Blood.

[52]  David R Fernandez,et al.  mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? , 2010, Discovery medicine.

[53]  T. Gaber,et al.  Effects of hypoxia and/or lack of glucose on cellular energy metabolism and cytokine production in stimulated human CD4+ T lymphocytes. , 2010, Immunology letters.

[54]  M. Fujimoto,et al.  Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. , 2010, Arthritis and rheumatism.

[55]  Daniel Rico,et al.  Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation , 2010, The Journal of Immunology.

[56]  Erika L. Pearce.  Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.

[57]  Russell G. Jones,et al.  Enhancing CD 8 T Cell Memory by Modulating Fatty Acid Metabolism , 2010 .

[58]  A. Ridley,et al.  Multiple roles for RhoA during T cell transendothelial migration , 2010, Small GTPases.

[59]  S. Kim,et al.  Hypoxic stress up‐regulates the expression of Toll‐like receptor 4 in macrophages via hypoxia‐inducible factor , 2010, Immunology.

[60]  B. Bresnihan,et al.  Extended Report , 2022 .

[61]  K. Frauwirth,et al.  Regulation of T lymphocyte metabolism , 2004, Brain, Behavior, and Immunity.

[62]  F. Buttgereit,et al.  Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases , 2010, Journal of internal medicine.

[63]  D. Veale,et al.  IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates , 2011, PloS one.

[64]  B. Pedersen.  Exercise-induced myokines and their role in chronic diseases , 2011, Brain, Behavior, and Immunity.

[65]  T. Gaber,et al.  Macrophage Migration Inhibitory Factor Counterregulates Dexamethasone-Mediated Suppression of Hypoxia-Inducible Factor-1α Function and Differentially Influences Human CD4+ T Cell Proliferation under Hypoxia , 2011, The Journal of Immunology.

[66]  R. Straub,et al.  Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases , 2011, Brain, Behavior, and Immunity.

[67]  D. Hardie.  AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. , 2011, Genes & development.

[68]  R. Straub.  [Neuroendocrine immunology: new pathogenetic aspects and clinical application]. , 2011, Zeitschrift fur Rheumatologie.

[69]  L. O’Neill,et al.  The emerging role of metabolic regulation in the functioning of Toll‐like receptors and the NOD‐like receptor Nlrp3 , 2011, FEBS letters.

[70]  J. Winderickx,et al.  The AMPK/SNF1/SnRK1 fuel gauge and energy regulator: structure, function and regulation , 2011, The FEBS journal.

[71]  J. O’Sullivan,et al.  Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. , 2011, Arthritis and rheumatism.

[72]  K. Kotoh,et al.  Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model , 2012, Journal of Gastroenterology.

[73]  T. Radstake,et al.  A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis , 2011, International journal of rheumatology.

[74]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[75]  D. Mathis,et al.  Immunometabolism: an emerging frontier , 2011, Nature Reviews Immunology.

[76]  Robert T Sauer,et al.  AAA+ proteases: ATP-fueled machines of protein destruction. , 2011, Annual review of biochemistry.

[77]  X. Chang,et al.  Glycolysis and rheumatoid arthritis , 2011, International journal of rheumatic diseases.

[78]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[79]  Thomas B. Sundberg,et al.  Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease , 2011, Science Translational Medicine.

[80]  D. Cantrell,et al.  Metabolism, migration and memory in cytotoxic T cells , 2011, Nature Reviews Immunology.

[81]  C. Hsieh,et al.  When T Cells Run Out of Breath: The HIF-1α Story , 2011, Cell.

[82]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[83]  Fabio Grassi,et al.  ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors , 2011, Science Signaling.

[84]  D. Shah,et al.  Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. , 2011, Immunobiology.

[85]  S. Côrte‐Real,et al.  Differential Modulation of ATP-Induced P2X7-Associated Permeabilities to Cations and Anions of Macrophages by Infection with Leishmania amazonensis , 2011, PloS one.

[86]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[87]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[88]  Kathryn Moynihan Ramsey,et al.  Circadian rhythms, sleep, and metabolism. , 2011, The Journal of clinical investigation.

[89]  M. Horton,et al.  Regulation of immune responses by mTOR. , 2012, Annual review of immunology.

[90]  L. Santos‐Argumedo,et al.  The myosin family: unconventional roles of actin‐dependent molecular motors in immune cells , 2012, Journal of leukocyte biology.

[91]  V. De Rosa,et al.  Intracellular metabolic pathways control immune tolerance. , 2012, Trends in immunology.

[92]  R. Straub,et al.  Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology , 2012, Journal of Molecular Medicine.

[93]  K. Inoki,et al.  AMPK and mTOR in cellular energy homeostasis and drug targets. , 2012, Annual review of pharmacology and toxicology.

[94]  T. Ota.  Obesity-Induced Inflammation and Insulin Resistance , 2014, Front. Endocrinol..